Pulse Biosciences Inc
NASDAQ:PLSE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pulse Biosciences Inc
NASDAQ:PLSE
|
US |
|
N
|
National Vision Holdings Inc
F:7NV
|
US |
|
N
|
Novo Nordisk A/S
F:NOVA
|
DK |
|
T
|
T-Mobile US Inc
F:TM5
|
US |
|
A
|
Astro Resources NL
ASX:ARO
|
AU |
|
A
|
Amphenol Corp
F:XPH
|
US |
|
B
|
Boryszew SA
WSE:BRS
|
PL |
|
WSFS Financial Corp
F:WF4
|
US |
|
Y
|
Yankuang Energy Group Co Ltd
SWB:YZCA
|
CN |
|
S
|
Sixt SE
SWB:SIX3
|
DE |
|
Takashimaya Co Ltd
OTC:TKSHF
|
JP |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Pulse Biosciences Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Pulse Biosciences Does
Pulse Biosciences develops medical technology that uses very short electrical pulses to destroy unwanted tissue without the heat and mechanical damage of traditional ablation tools. Its main product work centers on systems for treating skin conditions and other soft tissue targets, using a method the company calls nanosecond pulsed field ablation.
- Headquarters
- United States of America US
- Employees
- 116
- IPO date
- May 18, 2016